Hanlin Gao
CIK 1684532 · Chief Scientific Officer · last filed 2026-09-03
Hanlin Gao is a Chief Scientific Officer who has filed 87 SEC Form 4 insider transactions across 1 company since 2016. The most recent filing shows the insider sold $32.9K of FLGT on Sep 3, 2026. Across all open-market trades the lifetime net is −$3.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $21.9M across reported positions. 92 SEC filings were submitted jointly with Fulgent Genetics, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$21.89M
1
87
-$3.67M
Filer Profile
EL MONTE, CA 91731
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FLGT | Chief Scientific Officer | 986,117 | $22.20 | $21.89M | -$3.67M | 76 | 2026-09-03 |
Recent Filings
87 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-03 | FLGT | Sell (S) | −1,673 | -$32.9K | EDGAR |
| 2026-08-28 | FLGT | Sell (S) | −939 | -$18.7K | EDGAR |
| 2026-08-27 | FLGT | Notice (144) | −939 | -$18.7K | EDGAR |
| 2026-07-28 | FLGT | Tax (F) | −1,645 | -$32.4K | EDGAR |
| 2026-06-03 | FLGT | Sell (S) | −1,688 | -$30.2K | EDGAR |
| 2026-05-28 | FLGT | Sell (S) | −945 | -$16.6K | EDGAR |
| 2026-04-28 | FLGT | Tax (F) | −1,645 | -$26.8K | EDGAR |
| 2026-03-02 | FLGT | Tax (F) | −8,325 | -$136.1K | EDGAR |
| 2026-02-25 | FLGT | Mixed | +51,418 | -$362.5K | EDGAR |
| 2026-01-28 | FLGT | Tax (F) | −1,331 | -$36.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.